Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
13,033,369
-
Share change
-
+2,589,484
-
Total reported value
-
$184,956,981
-
Price per share
-
$14.19
-
Number of holders
-
72
-
Value change
-
+$36,613,314
-
Number of buys
-
39
-
Number of sells
-
18
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2020
As of 31 Mar 2020 Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) had 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,033,369 shares of stock of the company.
Largest 10 holders included Nantahala Capital Management, LLC, Avoro Capital Advisors LLC, BlackRock Inc., VANGUARD GROUP INC, Slate Path Capital LP, Corriente Advisors, LLC, MANGROVE PARTNERS, Prosight Management, LP, STATE STREET CORP, and 683 Capital Management, LLC.
This table shows 72 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.